HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lymphoma and immunosuppression: a report of a case associated with efalizumab therapy.

Abstract
Lymphomas have been associated with immunodeficiency disorders, including those acquired secondary to the use of immunosuppressants for autoimmune disorders and for the prevention of graft rejection. Biologic agents have also been associated with the development of lymphoproliferative disorders. We report the case of Epstein-Barr Virus- negative diffuse large B-cell lymphoma associated with efalizumab, a monoclonal antibody that inhibits T-cell activity. Discontinuation of efalizumab resulted in a partial remission of lymphoma, although administration of chemotherapy was ultimately required. The use of immunomodulators must be tempered with the knowledge of their effect on the immune system and their association with lymphoproliferative disorders.
AuthorsPamela MacKenzie, Qurat-ul-Ain Kamili, Alan Menter, Barry Cooper
JournalClinical lymphoma, myeloma & leukemia (Clin Lymphoma Myeloma Leuk) Vol. 10 Issue 1 Pg. E14-6 (Feb 2010) ISSN: 2152-2669 [Electronic] United States
PMID20223722 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • CD11a Antigen
  • L-Lactate Dehydrogenase
  • efalizumab
Topics
  • Antibodies, Monoclonal (adverse effects)
  • Antibodies, Monoclonal, Humanized
  • CD11a Antigen (analysis)
  • Herpesvirus 4, Human (isolation & purification)
  • Humans
  • Immune Tolerance
  • L-Lactate Dehydrogenase (blood)
  • Lymphoma, Large B-Cell, Diffuse (chemically induced, immunology, virology)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: